Skin Cancer

SKIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Skin Toxicity Program Can Positively Address EGFR Inhibitor-Related Skin Toxicities

Patients given prophylactic treatment were 94% less likely to require a first rescue treatment for rash and 74% less likely to require a second rescue treatment.
irAEs Linked to Ipilimumab Should Not Preclude Subsequent Anti–PD-1 Therapy

This retrospective study suggests that patients with prior ipilimumab-related adverse events related can safely retry anti–PD-1 therapy.
Use of ICIs for Advanced Melanoma in Taiwanese Patients

It was determined that ICIs were less efficacious in Taiwanese patients with melanoma.
Conflicts of Interest Continue to Plague Oncology Guidelines and Research

New research presented at ASCO 2020 sheds light on conflicts of interest among NCCN panelists and links industry dollars to measures of academic success among junior faculty.
Why Cancer Centers May Need to Rethink the Hard Sell to Patients

Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.

VIDEO SERIES

Recent Advances in Melanoma Therapy

Targeted Treatments and Immunotherapies for Melanoma

Tailoring Treatments in Melanoma

Drug Resistance in Melanoma

Affordability of Melanoma Care

Melanoma: Treatment-induced Toxicity

Immunotherapy: A Decade of Improvements in Melanoma

Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?

Melanoma: Checkpoints in the Pipeline

Targeting Therapy for Melanoma Subtypes

Melanoma: Targetable Genes in the Pipeline

Clinical Trials in Melanoma

SKIN CANCER NEWS

Investigators estimated the effects of immunosuppression on poor outcomes in multiple cutaneous squamous cell carcinoma.

Prior History of SCC Could Be a Red Flag for Development of SCC in the Setting of CLL

August 27, 2020

FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use

August 24, 2020

Measuring an adult patient's height.

Study Investigates Association Between Height and Risk of Invasive Melanoma

June 18, 2020

Racial minorities are poorly represented in genomic research databases, raising important questions

Racial Differences Seen in Time to Treatment for Melanoma

June 8, 2020

Drug adherence can be a challenge for both patients and clinicians.

Exposure to Antibiotics Associated With Survival Detriment in Patients With Advanced Melanoma Treated With ICIs

May 6, 2020

Next post in Skin Cancer

FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use